[HTML][HTML] Persistence of antibody responses to the SARS-CoV-2 in dialysis patients and renal transplant recipients recovered from COVID-19

M Cappuccilli, PF Bruno, A Spazzoli, M Righini… - Pathogens, 2021 - mdpi.com
Nephropathic subjects with impaired immune responses show dramatically high infection
rates of coronavirus disease 2019 (COVID-19). This work evaluated the ability to acquire …

[HTML][HTML] Immunomodulatory effects of thalidomide in an experimental brain death liver donor model

AC Santana, W Andraus, FMO Silva, H Dellê… - Scientific Reports, 2021 - nature.com
Brain death is characterized by a generalized inflammatory response that results in
multiorgan damage. This process is mainly mediated through cytokines, which amplify graft …

[PDF][PDF] Nirmatrelvir increases blood tacrolimus concentration in COVID-19 patients as determined by UHPLC-MS/MS method

QG Wu, LY Zeng, F Li, ZQ Zhu, L Yin… - Eur Rev Med …, 2023 - europeanreview.org
OBJECTIVE: Transplant recipients have a higher risk of SARS-CoV-2 infection owing to the
use of immunosuppressive drugs like tacrolimus (FK506). FK506 and nirmatrelvir (NMV)(an …

[HTML][HTML] COVID-19 infection frequency and clinical course in patients with liver transplantation: Results of a single transplant center in Türkiye

O Aydın, MK Çolakoğlu, V Öter, YM Özgün… - Turkish Journal of …, 2022 - ncbi.nlm.nih.gov
Objectives In this paper, it was tried to determine the incidence of COVID-19, course of the
disease, and mortality rate in liver transplant patients by evaluating all patients operated on …

Early pandemic in-hospital outcomes and mortality risk factors in COVID-19 solid organ transplant patients

L Alhuneafat, MU Khalid, A Jabri… - Baylor University …, 2024 - Taylor & Francis
Background Solid organ transplant (SOT) recipients with COVID-19 have a higher risk of
mortality than those without COVID-19. However, it is unclear how SOT patient outcomes …

Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations

M Andreoni, L Sticchi, S Nozza, L Sarmati… - Human Vaccines & …, 2021 - Taylor & Francis
Vaccination prevents 2–3 million deaths worldwide every year. Nevertheless, vaccine-
preventable diseases (VPDs) still cause a considerable number of deaths especially in …

[HTML][HTML] COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations

R Roshanshad, A Roshanshad… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus-2 is an ongoing health concern. In addition to affecting the respiratory …

[HTML][HTML] COVID-19 and Kidney Transplantation: Epidemiology, Histopathological Presentation, Clinical Presentation and Outcomes, and Therapeutic Strategies

M Salvadori, A Tsalouchos - Transplantology, 2022 - mdpi.com
Multiple case series of kidney transplant recipients with COVID-19 have shown increased
mortality compared to nontransplant patients. To date, we do not have high-level evidence to …

[HTML][HTML] Outcomes of COVID-19 in heart failure, LVAD, and heart transplant patients in an advanced heart failure practice

S George, LC Cunningham, DP Nelson… - American Heart Journal …, 2022 - Elsevier
Background Patients with heart failure face increased morbidity and mortality when infected
with COVID-19. The objective of this study was to evaluate the outcomes of patients with …

[HTML][HTML] A Comparison of COVID-19 and Influenza in Heart Transplant Recipients: A Nationwide Study in the United States

A Isath, A Malik, D Bandyopadhyay, A Goel… - … Canadian Journal of …, 2023 - ncbi.nlm.nih.gov
Methods We queried the National Inpatient Sample from 2019 to 2020 for all adult (≥ 18
years) hospitalizations for COVID-19 or influenza in patients with a history of HT. The …